Publications by authors named "M Assoumou"

Introduction: since the introduction of the anti-HBV vaccine into the Expanded Program on Immunization (EPI) in 2005 in Cameroon, vaccination coverage has reached 99.0%. This coverage would indicate an increase in the number of children immune to Hepatitis B Virus (HBV) and a decrease in susceptibility to HBV-infection.

View Article and Find Full Text PDF

Introduction: HIV-1 and Mtb are characterized by immune activation and unbalances production of cytokines, but the expression of IL33 in HIV/TB coinfection remain understudied. This study aimed to evaluate the level of IL-33 in plasma of HIV and M. tuberculosis (HIV/TB) coinfected patients compared to patients with respective mono infections in Yaoundé.

View Article and Find Full Text PDF

Background: The COVID-19 pandemic has caused a public health emergency in all sectors of society, including universities and other academic institutions in Cameroon. However, little is known concerning the real prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections among student communities during the second wave of infection in Cameroon. This study aimed to estimate SARS-CoV-2 antibodies seroprevalence among participants in a university community in Cameroon.

View Article and Find Full Text PDF
Article Synopsis
  • Distinct SARS-CoV-2 lineage B.1.620 was identified in Lithuania, featuring multiple mutations in the spike protein commonly found in concerning variants like E484K and S477N.
  • The study highlights the lineage's potential resistance to neutralizing antibodies and documents local instances of transmission in Europe, particularly in Lithuania.
  • Evidence suggests that B.1.620 likely originated in Central Africa, supported by advanced phylogeographic methods and travel history data from infected individuals.
View Article and Find Full Text PDF